The Global Bipolar Disorder Therapeutics Market is forescasted to grow at a CAGR of 2.38% during the period 2019-2023

Tuesday, October 23, 2018 Mental Health News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- About Bipolar DisorderBipolar disorder is also known as manic depression that

causes extreme shifts in mood, energy, and activity levels. Elevated mood swings are called mania or hypomania, which differs based on the severity and presence of psychosis. Bipolar disorder is a long-lasting condition that can be categorized into bipolar
I, bipolar II, and cyclothymia. This condition can be managed with a regular treatment. Insomnia, weight gain or loss, behavioral changes, and psychological imbalances are some of the symptoms witnessed in individuals with bipolar disorder.Read the full report: https://www.reportlinker.com/p04828786 Technavio's analysts forecast the Global Bipolar Disorder Therapeutics Market to grow at a CAGR of 2.38% during the period 2019-2023.Covered in this reportThe report covers the present scenario and the growth prospects of the bipolar disorder therapeutics market. To calculate the market size, the report considers the revenue generated from the application of bipolar disorder therapeutics across the globe.The market is divided into the following segments based on geography:• Americas• APAC• EMEATechnavio's report, bipolar disorder therapeutics market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.Key vendors• Allergan• AstraZeneca• Eli Lilly• GlaxoSmithKline• Johnson & JohnsonMarket driver• Growing prevalence of mental health disorders (MHDs) across the globe.• For a full, detailed list, view our reportMarket challenge• Lack of adequate diagnosis process• For a full, detailed list, view our reportMarket trend• Growing number of strategic alliances• For a full, detailed list, view our reportKey questions answered in this report• What will the market size be in 2023 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.Read the full report: https://www.reportlinker.com/p04828786 About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-global-bipolar-disorder-therapeutics-market-is-forescasted-to-grow-at-a-cagr-of-2-38-during-the-period-2019-2023--300735295.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store